Tumor angiogenesis

Journal of Investigative Dermatology Symposium Proceedings

Volumn 5, Issue 1, 2000, Pages 20-23

  Detmar, M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Skin; TSP 1; TSP 2; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; CELL RECEPTOR; PLACENTAL GROWTH FACTOR; THROMBOSPONDIN; THROMBOSPONDIN 1; THROMBOSPONDIN 2; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; CANCER INVASION; CONFERENCE PAPER; DOWN REGULATION; GROWTH INHIBITION; HUMAN; KAPOSI SARCOMA; METASTASIS; SQUAMOUS CELL CARCINOMA; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 0034508205     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1087-0024.2000.00003.x     Document Type: Conference Paper

References (56)

1. Thrombospondins: Structure and regulation of expression
2. Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1
3. A second thrombospondin gene in the mouse is similar in organization to thrombospondin 1 but does not respond to serum
4. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine
5. Molecular mediators of angiogenesis in bladder cancer
6. Properties of recombinant mouse thrombospondin 2 expressed in Spodoptera cells
7. Metabolism of thrombospondin 2. Binding and degradation by 3T3 cells and glycosaminoglycan-variant Chinese hamster ovary cells
8. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
9. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis
10. Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability
11. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
12. Thrombospondin-1 is a major activator of TGF-b1 in vivo
13. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells
14. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis
15. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin
16. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice
17. Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas
18. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
19. Malignant transformation of mouse primary keratinocytes by Harvey sarcoma vires and its modulation by surrounding normal cells
20. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
21. The role of angiogenesis in tumor growth
22. Angiogenesis and angiogenesis inhibition: An overview
23. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells
24. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
25. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
26. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats
27. Differential expression of thrombospondin 1, 2, and 3 during murine development
28. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
29. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3
30. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression
31. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
32. The distribution of the matricellular protein thrombospondin 2 in tissue of embryonic and adult mice
33. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis
34. Opposite regulation of thrombospondin-1 and corticotropin-induced secreted protein/thrombospondin-2 expression by adrenocorticotropic hormone in adrenocortical cells
35. Vascular endothelial growth factor is a secreted angiogenic mitogen
36. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo
37. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
38. Heparin-binding peptides from thrombospondin 1 and 2 contain focal adhesion-labilizing activity
39. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
40. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
41. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth
42. Fetal liver kinase. 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium
43. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
44. Vascular endothelial growth factor-C (CVEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma
45. Halting angiogenesis suppresses carcinoma cell invasion
46. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain
47. Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis
48. Overexpression of thrombospondin- 1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas
49. Identification of a new endothelial cell growth factor receptor tyrosine kinase
50. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
51. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
52. Inhibition of angiogenesis by thrombospondin-2
53. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis
54. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis
55. Light microscopic immunolocation of thrombospondin in human tissues
56. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines